$ Value
$0
Shares
164,500
Price
$0
Filed
Feb 3
Insider
Name
Hawryluk P. Kent
Title
President & CEO
CIK
0001673991
Roles
Transaction Details
Transaction Date
2026-02-02
Code
A
Table
Derivative
Ownership
Direct
Equity Swap
No
Shares After
164,500
Footnotes
Represents the grant of restricted stock units (RSUs). The RSUs will vest over a four (4) year period in equal quarterly installments, subject to the Reporting Person's continued service on such vesting date. | Shares held by the P. Kent Hawryluk Revocable Trust dated January 25, 2011, of which the Reporting Person serves as trustee. The Reporting Person disclaims beneficial ownership except to the extent of any pecuniary interest therein, and this report shall not be deemed an admission that such shares are beneficially owned by him for Section 16 or any other purpose. | The shares underlying this option vest and become exercisable in forty eight (48) equal monthly installments, beginning on March 2, 2026, subject to the Reporting Person's continued service on such vesting date.
Filing Info
Hawryluk P. Kent's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-13 | MBX | ▲ | $526K ★ |
| 2026-02-26 | MBX | M | $460K |
| 2026-02-26 | MBX | M | $0 |
| 2026-02-02 | MBX | A | $0 |
| 2026-02-02 | MBX | A | $0 |
| 2025-10-24 | MBX | M | $594K |
| 2025-10-24 | MBX | M | $0 |
| 2025-10-20 | MBX | ▲ | $273K |
Other Insiders at MBX (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
Hawryluk P. Kent
President & CEO
|
$526K | — | 2026-03-13 |
| Hoerter Steven L. | — | — | 2025-11-22 |
|
Bartram Richard
Chief Financial Officer
|
— | — | 2026-02-02 |
|
Azoulay Salomon
Chief Medical Officer
|
— | — | 2026-02-02 |